Viewing data from:

PROPAFENONE HYDROCHLORIDE

ANDA

PROPAFENONE HYDROCHLORIDE | A078540 | STRIDES PHARMA INTERNATIONAL AG

3 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-08-26 | 7 NDCs

Highest NADAC/Unit

$0.5650

per ea

Lowest NADAC/Unit

$0.3557

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
64380018601PROPAFENONE HCL ER 425 MG CAP	$0.5650	EA	Generic	—	2026-08-19
64380018501PROPAFENONE HCL ER 325 MG CAP	$0.5300	EA	Generic	—	2026-08-19
64380018502PROPAFENONE HCL ER 325 MG CAP	$0.5300	EA	Generic	—	2026-08-19
64380018504PROPAFENONE HCL ER 325 MG CAP	$0.5300	EA	Generic	—	2026-08-19
64380018402PROPAFENONE HCL ER 225 MG CAP	$0.3557	EA	Generic	—	2026-08-19
64380018404PROPAFENONE HCL ER 225 MG CAP	$0.3557	EA	Generic	—	2026-08-19
64380018401PROPAFENONE HCL ER 225 MG CAP	$0.3557	EA	Generic	—	2026-08-19

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 6 NDCs (6 FSS)

Lowest Price

$18.25

Highest Price

$356.50

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
64380-0184-01PROPAFENONE HCL 225MG CAP,SA	$18.25	FSS	AvKare, LLC	06/14/2028
64380-0184-02PROPAFENONE HCL 225MG CAP,SA	$41.76	FSS	AvKare, LLC	06/14/2028
64380-0184-04PROPAFENONE HCL 225MG CAP,SA	$232.52	FSS	AvKare, LLC	06/14/2028
64380-0185-01PROPAFENONE HCL 325MG CAP,SA	$22.70	FSS	AvKare, LLC	06/14/2028
64380-0185-02PROPAFENONE HCL 325MG CAP,SA	$64.17	FSS	AvKare, LLC	06/14/2028
64380-0185-04PROPAFENONE HCL 325MG CAP,SA	$356.50	FSS	AvKare, LLC	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain7 active DMFs4 inactive

7 active API suppliers hold Drug Master Files for this ingredient.

PHARMAZELL GMBHPROPAFENONE HYDROCHLORIDE

DMF 106411993

PROCOS SPAPROPAFENONE HYDROCHLORIDE

DMF 114261995

ERREGIERRE SPAPROPAFENONE HYDROCHLORIDE USP-EP

DMF 130101998

SCI PHARMTECH INCPROPAFENONE HYDROCHLORIDE

DMF 235372010

ZYDUS LIFESCIENCES LTDPROPAFENONE HYDROCHLORIDE USP

DMF 250552011

EMCURE PHARMACEUTICALS LTDPROPAFENONE HYDROCHLORIDE USP

DMF 255882012

CHANGZHOU RUIMING PHARMACEUTICAL CO LTDPROPAFENONE HYDROCHLORIDE

DMF 379642023

ORGAMOL SAInactivePROPAFENONE HYDROCHLORIDE

DMF 83111989

SIEGFRIED CHEMIE AG LTDInactivePROPAFENONE HYDROCHLORIDE

DMF 126911997

CAMBREX PROFARMACO MILANO SRLInactivePROPAFENONE HYDROCHLORIDE

DMF 149852000

MYLAN LABORATORIES LTDInactivePROPAFENONE HYDROCHLORIDE USP

DMF 204182007

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Oct 20, 2010	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (3)

Sort:

#001 — 225MG

0 patents0 exclusivities▴

CAPSULE, EXTENDED RELEASE;ORAL | Approved: Oct 18, 2010

No patent or exclusivity listings for this strength.

#002 — 325MG

0 patents0 exclusivities▾

CAPSULE, EXTENDED RELEASE;ORAL | Approved: Oct 18, 2010

#003 — 425MG

0 patents0 exclusivities▾

CAPSULE, EXTENDED RELEASE;ORAL | Approved: Oct 18, 2010